Safety and efficacy of topical minoxidil in the management of androgenetic alopecia.

Abstract

Of 149 subjects with androgenetic alopecia, 102 completed 1 year of a double-blind, randomized study comparing 2% minoxidil and 3% minoxidil solutions for safety and efficacy. One third of the subjects used a vehicle placebo for the first 4 months and then switched to 3% minoxidil. At 12 months the 2% minoxidil group switched to a 3% solution. During months… (More)

Topics

Cite this paper

@article{Rietschel1987SafetyAE, title={Safety and efficacy of topical minoxidil in the management of androgenetic alopecia.}, author={Robert L Rietschel and S. H. Duncan}, journal={Journal of the American Academy of Dermatology}, year={1987}, volume={16 3 Pt 2}, pages={677-85} }